More recently, a study assessing the incidence of cancers in mice with a P53 (p53Ala135Val/wt) mutation found that 80% of mice that received implants of DMBA-coated suture into their ovaries developed ovarian tumors, of which 50% were adenocarcinomas when evaluated 3 months after implantation[22]. This evidence concerns the gene TP53 and cancer.